XTANT MEDICAL HOLDINGS, INC. Restructuring Costs
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Restructuring Costs of $200.00 thousand for the 0-month period ending 2018-02-13, per its 10-Q filed 2018-08-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2018-08-08
- 2018-02-13: Restructuring Costs 0 month $200.00K.
| Period end | Restructuring Costs 0 month |
|---|---|
| 2018-02-13 | $200.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |